AU1338901A - Drug target isogenes: polymorphisms in the cholinergic receptor, muscarinic 5 gene - Google Patents

Drug target isogenes: polymorphisms in the cholinergic receptor, muscarinic 5 gene

Info

Publication number
AU1338901A
AU1338901A AU13389/01A AU1338901A AU1338901A AU 1338901 A AU1338901 A AU 1338901A AU 13389/01 A AU13389/01 A AU 13389/01A AU 1338901 A AU1338901 A AU 1338901A AU 1338901 A AU1338901 A AU 1338901A
Authority
AU
Australia
Prior art keywords
muscarinic
polymorphisms
gene
drug target
cholinergic receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU13389/01A
Inventor
Anne Chew
Julie Y. Choi
Krishnan Nandabalan
J. Claiborne Stephens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogenics Inc
Original Assignee
Genaissance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals Inc filed Critical Genaissance Pharmaceuticals Inc
Publication of AU1338901A publication Critical patent/AU1338901A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/125—Allele specific primer extension
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
AU13389/01A 1999-10-21 2000-10-19 Drug target isogenes: polymorphisms in the cholinergic receptor, muscarinic 5 gene Withdrawn AU1338901A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16064799P 1999-10-21 1999-10-21
US60160647 1999-10-21
PCT/US2000/029071 WO2001028995A2 (en) 1999-10-21 2000-10-19 Drug target isogenes: polymorphisms in the cholinergic receptor, muscarinic 5 gene

Publications (1)

Publication Number Publication Date
AU1338901A true AU1338901A (en) 2001-04-30

Family

ID=22577784

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13389/01A Withdrawn AU1338901A (en) 1999-10-21 2000-10-19 Drug target isogenes: polymorphisms in the cholinergic receptor, muscarinic 5 gene

Country Status (2)

Country Link
AU (1) AU1338901A (en)
WO (1) WO2001028995A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225326A (en) * 1988-08-31 1993-07-06 Research Development Foundation One step in situ hybridization assay

Also Published As

Publication number Publication date
WO2001028995A8 (en) 2001-05-17
WO2001028995A2 (en) 2001-04-26

Similar Documents

Publication Publication Date Title
HK1045650A1 (en) Pharmaceutical composition.
MXPA01012478A (en) Improved pharmaceutical formulations.
ZA200000857B (en) Pharmaceutical composition.
ZA200203707B (en) Pharmaceutical combinations.
AU7119400A (en) Single nucleotide polymorphisms in genes
AU5786300A (en) Muscarinic antagonists
AU6492400A (en) Drug target isogenes: polymorphisms in the prostaglandin-endoperoxide synthase 2gene
AU2579001A (en) Drip resistant polymer composition
AU2000263446A1 (en) Drug target isogenes: polymorphisms in the interleukin 4 receptor alpha gene
AU6110700A (en) Drug target isogenes: polymorphisms in the dopamine receptor d2 gene
AU1081401A (en) Drug target isogenes: polymorphisms in the m1 muscarinic acetylcholine receptor gene
AU2258601A (en) Ibd-related polymorphisms
AU1338901A (en) Drug target isogenes: polymorphisms in the cholinergic receptor, muscarinic 5 gene
AU7388700A (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine receptor 1a gene
AU2000280150A1 (en) Drug target isogenes: polymorphisms in the cholinergic receptor, muscarinic 2 gene
AU2000280165A1 (en) Drug target isogenes: polymorphisms in the cholinergic receptor, muscarinic 3 gene
AU1331701A (en) Screening for disease susceptibility by genotyping the ccr5 and ccr2 genes
AU6343400A (en) Drug target isogenes: polymorphisms in the osteoclastogenesis inhibitory factor gene
AU2001213316A8 (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1d gene
AU6755300A (en) Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene
AU1773501A (en) Human single nucleotide polymorphisms
AU2000236029A1 (en) Receptor isogenes: polymorphisms in the tissue necrosis factor receptor
AU2001213316A1 (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1d gene
AU7994500A (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1b gene
AU1570701A (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1e gene

Legal Events

Date Code Title Description
MK13 Application withdrawn section 141(2)/reg 8.3(2) - pct appl. non-entering nat. phase, withdrawn by applicant